Table 1.
Predictors of high-volume (>30 ml) hemorrhage in univariate analysis
| Patient characteristics | Patients, n (%) | Odds ratio (95% confidence interval) | p value | |
|---|---|---|---|---|
| ICH ≤30 ml | ICH >30 ml | |||
| Patients evaluated | 86 (65) | 47 (35) | ||
| Age <60 years | 50 (58) | 34 (72) | 0.53 (0.24–1.14) | 0.10 |
| Male gender | 48 (55.8) | 38 (80.9) | 3.34 (1.44–7.75) | 0.005 |
| Duration of hypertension | ||||
| >10 years | 43 (50) | 13 (27.7) | 0.39 (0.16–0.92) | 0.07 |
| Anti-hypertensive treatment | ||||
| 1 anti-hypertensive agent | 34 (40.5) | 16 (35.6) | 0.39 (0.17–0.90) | 0.069 |
| ≥2 anti-hypertensive agents | 7 (8) | 24 (51) | 14.92 (3.46–45.57) | <0.001 |
| Poor compliance | 8 (9.3) | 17 (36.2) | 10.09 (2.57–39.60) | 0.001 |
| BP control | ||||
| Regular home monitoring | 74 (86) | 35 (74.5) | 0.47 (0.19–1.15) | 0.10 |
| Poor during the last month | 64 (74.4) | 40 (85.1) | 0.50 (0.19–1.30) | 0.15 |
| By a physician during the last 3 months | 10 (11.6) | 8 (17) | 1.55 (0.57–4.26) | 0.38 |
| Diabetes mellitus | 16 (19) | 7 (15) | 0.73 (0.35–1.96) | 0.09 |
| Duration > 10 years | 5 (6) | 2 (4) | 0.51 (0.22–0.97) | 0.098 |
| Blood glucose >150 mg/dl on admission | 14 (16) | 5 (10) | 0.97 (0.35–2.13) | 0.63 |
| Dyslipidemia | 8 (9) | 3 (6) | 0.55 (0.11–1.19) | 0.11 |
| Statin treatment at home | 3 (4) | 1 (2) | 0.21 (0.09–0.87) | 0.22 |
| Smoking status | 13 (15) | 7 (15) | 0.47 (0.11–1.25) | 0.9 |
| Medication | ||||
| Anti-platelets | 35 (41) | 14 (30) | 1.02 (0.54–3.15) | 0.06 |
| Warfarin | 2 (2) | 6 (13) | 7.55 (1.24–19.55) | 0.05 |
| Platelet count <50,000 on admission | 8 (9) | 3 (6) | 0.83 (0.31–2.01) | 0.09 |
| INR >3.0 on admission | 1 | 5 (10) | 10.50 (2.25–31.45) | 0.04 |